Bufexamac

Contraindicated

Bufexamac Ketorolac Acular Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details Bufexamac Ketorolac Injection Acular Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details Bufexamac Ketorolac Nasal Spray Sprix Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details Bufexamac Ketorolac Ophthalmic Acular Enhanced gastrointestinal adverse effects (peptic ulcers, gastrointestinal bleeding and/or perforation) Details

Major

Bufexamac Amitriptyline Elavil Explained An increased risk of bleeding Details Bufexamac Sertraline Explained An increased risk of bleeding Details Bufexamac Apixaban Eliquis Explained An increased risk of bleeding Details Bufexamac Aspirin Acuprin® An increased risk of bleeding, decreased renal function, and an increased risk of gastrointestinal adverse events Details Bufexamac Aspirin Rectal Aspirin An increased risk of bleeding, decreased renal function, and an increased risk of gastrointestinal adverse events Details Bufexamac Betrixaban Bevyxxa® An increased risk of bleeding Details Bufexamac Anagrelide Agrylin An increased risk of bleeding Details Bufexamac Bromfenac Ophthalmic Bromday® Increased risk of bleeding Details Bufexamac Budesonide Entocort Increased risk of gastrointestinal ulcer or bleeding Details Bufexamac Budesonide Nasal Spray Rhinocort Increased risk of gastrointestinal ulcer or bleeding Details Bufexamac Budesonide Oral Inhalation Pulmicort Increased risk of gastrointestinal ulcer or bleeding Details Bufexamac Clopidogrel Plavix An increased risk of bleeding Details Bufexamac Cyclosporine Injection Atopica An increased risk of cycloSPORINE nephrotoxicity Details Bufexamac Cyclosporine Ophthalmic Cequa An increased risk of cycloSPORINE nephrotoxicity Details Bufexamac Dabigatran Pradaxa® An increased risk of bleeding Details Bufexamac Dabigatran Etexilate An increased risk of bleeding Details Bufexamac Dalteparin Injection Fragmin An increased risk of bleeding Details Bufexamac Deflazacort Emflaza Increased risk of gastrointestinal ulcer or bleeding Details Bufexamac Dexamethasone Injection Decadron Increased risk of gastrointestinal ulcer or bleeding Details Bufexamac Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Increased risk of gastrointestinal ulcer or bleeding Details Bufexamac Digoxin Cardoxin® Increased digoxin exposure and prolonged half-life of digoxin Details Bufexamac Dipyridamole Permole® An increased risk of bleeding Details Bufexamac Edoxaban Savaysa An increased risk of bleeding Details Bufexamac Emtricitabine Emtriva Increased emtricitabine exposure and an increased risk of emtricitabine-related adverse effects Details Bufexamac Enoxaparin Lovenox An increased risk of bleeding Details Bufexamac Enoxaparin Injection Lovenox An increased risk of bleeding Details Bufexamac Epoprostenol Flolan An increased risk of bleeding Details Bufexamac Etodolac Lodine Increased risk of bleeding Details Bufexamac Fenoprofen Fenopron Increased risk of bleeding Details Bufexamac Flurbiprofen Ansaid Increased risk of bleeding Details Bufexamac Flurbiprofen Ophthalmic Ocufen Increased risk of bleeding Details Bufexamac Fondaparinux Arixtra An increased risk of bleeding Details Bufexamac Fondaparinux Injection Arixtra An increased risk of bleeding Details Bufexamac Furosemide Injection Disal Reduced diuretic effectiveness and possible nephrotoxicity Details Bufexamac Heparin An increased risk of bleeding Details Bufexamac Heparin Injection Lipo-Hepin® An increased risk of bleeding Details